Abstract
Patients with Alzheimer's disease (AD) and Parkinson's disease (PD) develop a progressive decline of visual function, which often aggravates cognitive and motor abilities. This study collected neurophthalmologic and orthoptic parameters, including optical coherence tomography (OCT) and facial emotion recognition (FER), in patients with early AD, PD, and healthy controls. Results demonstrate significant retinal thinning and eye alignment issues in patients, alongside deficits in emotion recognition. These findings suggest that visual rehabilitation could improve quality of life and reduce fall risks in these populations.
Introduction
While Alzheimer’s and Parkinson’s diseases are primarily characterized by cognitive and motor impairments, visual dysfunction is a frequent, yet often overlooked, early symptom. Patients commonly report blurred vision, reading difficulties, and light sensitivity. However, these symptoms are frequently dismissed as part of "normal aging," leading to an underestimation of their clinical significance. This study addresses the lack of standardized protocols for identifying pathological visual decline in early-stage neurodegenerative diseases, advocating for the use of neuro-ophthalmologic assessments in routine outpatient care.
Methods
The study involved a multi-modal assessment of 6 AD patients, 6 PD patients, and 8 healthy controls. The evaluation included:
- Standard Neuro-ophthalmologic Exam: Visual acuity (Snellen chart) and color sensitivity (Ishihara testing).
- Orthoptic Evaluation: Measurement of the Near Point of Convergence (NPC) and the Cover Test for eye deviations (heterophorias).
- Optical Coherence Tomography (OCT): Measurement of the Retinal Nerve Fiber Layer (RNFL) and Ganglion Cell Layer (GCL) thickness.
- Facial Emotion Recognition (FER): Patients identified six basic emotions (happiness, sadness, anger, fear, surprise, and disgust) using the Ekman database via custom software.
Results and Discussion
The Retina as a Biomarker
The eye serves as an accessible window into the central nervous system. OCT imaging revealed significant thinning of the retinal layers in both AD and PD patients compared to healthy controls.
As shown in the RNFL analysis, the average thickness was notably lower in patients (AD: 86.91 µm; PD: 89.67 µm) than in controls (95.63 µm). Similarly, the GCL showed significant reduction, particularly in the superior and nasal sectors.
Eye Alignment and Functional Vision
Convergence Insufficiency (CI) was pervasive among patients. PD patients, in particular, showed a high prevalence of exophoria at near distances, leading to a "remote" Near Point of Convergence (NPC > 10cm). This misalignment explains the frequent complaints of reading discomfort and spatial disorientation, despite many patients maintaining "normal" visual acuity on standard charts.
Emotion Recognition Deficits
Both AD and PD patients struggled significantly with recognizing negative emotions. AD patients had the most difficulty with sadness, while PD patients struggled with fear. On average, patients made 15-16 errors per test, compared to just 2.9 errors in the control group, suggesting distinct impacts on the brain's ventral affective system.
Conclusion
Despite the small sample size, this study highlights that visual and ocular defects are measurable early markers of AD and PD. Many of these issues, such as convergence insufficiency or glare, are treatable through prismatic lenses, specialized filters, or orthoptic exercises. Implementing these rehabilitative approaches could significantly enhance motor autonomy and reduce the risk of falls, improving the daily lives of patients with neurodegenerative diseases.
Summary updated